Eden Research plc (LON:EDEN – Get Free Report)’s stock price shot up 2.8% on Tuesday following insider buying activity. The stock traded as high as GBX 4.18 ($0.05) and last traded at GBX 3.70 ($0.05). 12,234,783 shares traded hands during mid-day trading, an increase of 664% from the average session volume of 1,602,016 shares. The stock had previously closed at GBX 3.60 ($0.04).
Specifically, insider Alexander John Abrey acquired 540,540 shares of the company’s stock in a transaction dated Tuesday, January 28th. The stock was bought at an average cost of GBX 4 ($0.05) per share, with a total value of £21,621.60 ($26,902.58).
Eden Research Price Performance
The company has a quick ratio of 2.42, a current ratio of 3.80 and a debt-to-equity ratio of 1.25. The firm’s 50-day moving average is GBX 3.88 and its 200-day moving average is GBX 4.02. The company has a market cap of £19.73 million, a PE ratio of -200.00 and a beta of 0.92.
Eden Research Company Profile
Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.
Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.
Featured Articles
- Five stocks we like better than Eden Research
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- What Does the Future Hold for Eli Lilly?
- How to Use the MarketBeat Excel Dividend Calculator
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
- What is a Stock Market Index and How Do You Use Them?
- 3 Consumer Stocks Call Option Traders Are Betting Big On
Receive News & Ratings for Eden Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eden Research and related companies with MarketBeat.com's FREE daily email newsletter.
